Delivery Order SPE2DB24D2101-SPE2DB25FKLAP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for supply of Trulicity 0.75 mg/0.5 ml pens valued at $1,184.18, with completion scheduled for August 12, 2025. This competitive award, issued without set-aside provisions, represents a firm fixed-price delivery order for the diabetes medication to support federal healthcare requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,970.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and carries firm fixed pricing with no set-aside designation. The award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's...
- The Defense Logistics Agency awarded a $7,436.37 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 4, 2025, with completion scheduled for August 5, 2025. This contract employs firm fixed pricing and was competitively awarded without set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a ceiling value of $1,735.26. This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement. The contract carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a $9,577.88 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with completion scheduled for September 5, 2025. This contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to a qualified vendor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $1,351.35 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed price, competitively awarded contract involves the supply of the diabetes medication from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger contract vehicle with the Defense...
- The Defense Logistics Agency awarded a $9,888.75 delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Trulicity 3 mg/0.5 mL pens with a completion date of June 6, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded through an open procurement process. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting federal medical procurement needs. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,086.69 to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL dosage units), with completion scheduled for September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a discrete pharmaceutical procurement...
- The Defense Logistics Agency awarded a $2,015.65 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, on August 8, 2025, with completion expected by August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger relationship with the federal...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKLAPDelivery Order
The Defense Logistics Agency awarded a $9,493.29 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL), a diabetes medication. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open federal procurement processes. The contract is scheduled for ultimate completion on June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor vehicle enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen consistently fulfills delivery orders across multiple therapeutic domains through DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 6/2/25 |